The FDA is giving emergency authorization to the experimental treatment that President Trump was given while he had coronavirus.
The antibody treatment created by Regeneron is made of two powerful antibodies that have shown promise in early studies.
The approval is limited to patients who have a high chance of developing severe symptoms of COVID-19.
Evidence shows the treatment works when given early in the course of the infection.